English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Kacie Whaley
| Sep 1, 2017
Rare disease therapy company, Shire, making executive changes
Marian Johns
| Aug 29, 2017
Shire, MircoHealth partner on app for hemophilia patients
Nicholas Gueguen
| Aug 1, 2017
Immunodeficiency disease patients report higher quality of life with CUVITRU treatment
Erianne Leatherman
| May 22, 2017
Shire outlines ADHD research at American Psychiatric Association meeting
Robert Hadley
| Apr 7, 2017
FDA accelerates review for drug that treats blood-clotting disease
Gene Johnson
| Mar 5, 2017
Shire honors Rare Disease Day with launch of 'Rare Count'
Keri Carbaugh
| Feb 17, 2017
Shire provides latest data on Hunter's syndrome, Gaucher disease
Keri Carbaugh
| Jan 8, 2017
Shire names Clark non-executive director
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
